10.1016/j.freeradbiomed.2019.06.019 Summary Keywords obesity, semaglutide, gut microbiota, metabolomics, fecal microbiota transplantation Citation Sun L, Shang B, Lv S, Liu G, Wu Q and Geng Y (2025) Effects of semaglutide on metabolism and gut microbiota in high-fat diet-induced obese mice
Periorificial dermatitis (small, red, inflamed bumps around the nose, mouth, or eyes) can be one of the first signs of deficiency, developing within three weeks of low intake
This pharmacokinetic profile means consistent appetite control without the peaks and valleys that shorter acting medications sometimes produce
Starting elderly patients at 2.5 mg remains appropriate, but extending each dose tier to 6 to 8 weeks rather than 4 weeks improves tolerability
Read the announcement here: Everyones talking about GLP-1s